We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current VERA market cap is 1.93B. The company's latest EPS is USD -1.7548 and P/E is -20.09.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -31.26M | -21.97M | -21.76M | -27.03M | -31.11M |
Net Income | -30.07M | -20.16M | -20.1M | -25.66M | -28.38M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -11.96M | -52.24M | -34.4M | -90.9M | -102.01M |
Net Income | -11.85M | -53.41M | -32.61M | -89.06M | -95.99M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 209.6M | 195.18M | 175.62M | 175.55M | 419.36M |
Total Liabilities | 51.9M | 54.66M | 51.91M | 73.86M | 65.81M |
Total Equity | 157.71M | 140.52M | 123.71M | 101.69M | 353.54M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 5.38M | 54.55M | 83.75M | 131.44M | 175.55M |
Total Liabilities | 1.83M | 4.33M | 14.16M | 54.53M | 73.86M |
Total Equity | -36.55M | -89.35M | 69.59M | 76.91M | 101.69M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -26.29M | -44.06M | -67.04M | -92.18M | -33.83M |
Investing | 12.23M | -74.22M | -57.99M | -39.43M | -219.29M |
Financing | 107.98M | 108.42M | 108.71M | 133.54M | 276.54M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -10.29M | -34.81M | -23.71M | -67.6M | -92.18M |
Investing | -125k | -42k | -4.2M | -70.55M | -39.43M |
Financing | -137k | 85.29M | 53.88M | 101.93M | 133.54M |
Market Cap | 1.93B |
Price to Earnings Ratio | -20.09 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 42.21 |
Price to Book Ratio | 18.96 |
Dividend Yield | - |
Shares Outstanding | 54.7M |
Average Volume (1 week) | 969.8k |
Average Volume (1 Month) | 783.76k |
52 Week Change | 103.05% |
52 Week High | 50.78 |
52 Week Low | 9.24 |
Spread (Intraday) | 14.22 (39.01%) |
Company Name | Vera Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://veratx.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions